Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Complement C3b Activator, Antigen, Antiserum, Control

FDA product code DAC · 2 cleared devices

Class 2 Immunology
Regulation
21 CFR 866.5260
Review panel
IM
Implant
No
Life sustaining
No
Third party review
Yes
GMP exempt
No
Clearance span
1977-09-02 – 1989-04-14
↑